dc.contributor |
Landspitali - The National University Hospital of Iceland |
dc.contributor.author |
Hilmarsdóttir, Ingibjörg |
dc.contributor.author |
Arnardóttir, Eva Mjöll |
dc.contributor.author |
Jóhannesdóttir, Elísabet Reykdal |
dc.contributor.author |
Golparian, Daniel |
dc.contributor.author |
Unemo, Magnus |
dc.date.accessioned |
2022-02-24T15:22:08Z |
dc.date.available |
2022-02-24T15:22:08Z |
dc.date.issued |
2021-02 |
dc.identifier.citation |
Hilmarsdóttir , I , Arnardóttir , E M , Jóhannesdóttir , E R , Golparian , D & Unemo , M 2021 , ' Chlamydia trachomatis in iceland : Prevalence, clinico-epidemiological features and comparison of cobas 480 ct/ng and aptima combo 2 (ct/ng) for diagnosis ' , Acta Dermato-Venereologica , vol. 101 , no. 2 , adv00393 , pp. adv00393 . https://doi.org/10.2340/00015555-3762 |
dc.identifier.issn |
0001-5555 |
dc.identifier.other |
42890422 |
dc.identifier.other |
8262e398-2289-4642-aea5-59c1bbcbb9d6 |
dc.identifier.other |
85101197924 |
dc.identifier.other |
33554267 |
dc.identifier.other |
000632449200001 |
dc.identifier.uri |
https://hdl.handle.net/20.500.11815/2921 |
dc.description |
Publisher Copyright: © 2021, Medical Journals/Acta D-V. All rights reserved. |
dc.description.abstract |
The aims of this study were to assess the prevalence of, and risk factors for, Chlamydia trachomatis in at-tendees recruited prospectively from October 2018 to January 2019 at the only sexually transmitted infections clinic in Iceland (in Reykjavík), and to eva-luate the cobas 4800 CT/NG Test and Aptima Combo 2 Assay for C. trachomatis detection in male urine and female vaginal swabs. Prevalence of C. trachomatis was 15.8% among 487 women and 13.6% among 491 men (no Neisseria gonorrhoeae positive patients were found). C. trachomatis detection was independently and positively associated with being tested for contact tracing, 18–24 years of age, and reporting ≥ 6 sexual partners within 12 months. Reporting sex with non-residents of Iceland was associated with a lower risk of C. trachomatis infection. Both assays had a high sen-sitivity in detection of C. trachomatis (Aptima Combo 2: 100%; cobas 4800 CT/NG: 95.1%) and high speci-ficity (100% and 99.6%, respectively). The high local prevalence of C. trachomatis and increased acquisition risk following sex with residents are of public health concern. |
dc.format.extent |
6 |
dc.format.extent |
358079 |
dc.format.extent |
adv00393 |
dc.language.iso |
en |
dc.relation.ispartofseries |
Acta Dermato-Venereologica; 101(2) |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
Kynsjúkdómar |
dc.subject |
Klamýdía |
dc.subject |
Ísland |
dc.subject |
Ísland |
dc.subject |
Áhættuþættir |
dc.subject |
Algengi sjúkdóma |
dc.subject |
Chlamydia trachomatis |
dc.subject |
Iceland |
dc.subject |
Neisseria gonorrhoeae |
dc.subject |
Nucleic acid amplification |
dc.subject |
Prevalence |
dc.subject |
Risk factor |
dc.subject |
Sexually transmitted disease |
dc.subject |
Chlamydia trachomatis/genetics |
dc.subject |
Chlamydia Infections/diagnosis |
dc.subject |
Humans |
dc.subject |
Male |
dc.subject |
Tomography, X-Ray Computed |
dc.subject |
Sensitivity and Specificity |
dc.subject |
Female |
dc.subject |
Gonorrhea/diagnosis |
dc.subject |
Iceland/epidemiology |
dc.subject |
Dermatology |
dc.title |
Chlamydia trachomatis in iceland : Prevalence, clinico-epidemiological features and comparison of cobas 480 ct/ng and aptima combo 2 (ct/ng) for diagnosis |
dc.type |
/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article |
dc.description.version |
Peer reviewed |
dc.identifier.doi |
10.2340/00015555-3762 |
dc.relation.url |
http://www.scopus.com/inward/record.url?scp=85101197924&partnerID=8YFLogxK |
dc.contributor.department |
Faculty of Medicine |
dc.contributor.department |
Clinical Laboratory Services, Diagnostics and Blood Bank |
dc.contributor.department |
Other departments |
dc.contributor.department |
Internal Medicine and Emergency Services |